Syneos Health (Syneos Health) Momentum Rank : 0 (As of May. 05, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Syneos Health Momentum Rank?

Syneos Health has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Syneos Health Momentum Rank Related Terms

Thank you for viewing the detailed overview of Syneos Health's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Syneos Health (Syneos Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (NAS:SYNH) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

1030 Sync Street, Morrisville, NC, USA, 27560-5468

Website

https://www.syneoshealth.com

Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Executives

Michael J. Bonello	officer: Chief Financial Officer	4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612
Stanford Rudnick	officer: See remarks	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Christian Tucat	officer: Chief Business Officer	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560-5468
Michael Lee Brooks	officer: See remarks	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jonathan Olefson	officer: General Counsel & Corp Secty	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Michelle Keefe	officer: Pres., Commercial Solutions	C/O SYNEOS HEALTH,INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Jason M. Meggs	officer: Chief Financial Officer	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Donna Hildebrand Kralowetz	officer: SVP, Chief Accounting Officer	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
Matthew E. Monaghan	director	ONE INVACARE WAY, ELYRIA OH 44035
Alfonso G Zulueta	director	4925 INDIANA AVE, LISLE IL 60532
Barbara W. Bodem	director	C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Linda S Harty	director	MEDTRONIC PLC, 710 MEDTRONIC PARKWAY NE, LC-150, MINNEAPOLIS MN 55432
Alistair Macdonald	officer: Chief Operating Officer	C/O SYNEOS HEALTH, INC., 1030 SYNC STREET, MORRISVILLE NC 27560
David S. Wilkes	director	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Advent International Corp/ma	10 percent owner	800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199